CD28 and neoplasm: Previous studies have suggested that exhausted, antigen-experienced CD8+ Tem cells within tumor may be derived from TCF1+CD28+ stem-like T cell (Tscm) precursors that localize to antigen presenting cell-rich niches within tumors (44).